Suppr超能文献

一项比较对乙酰氨基酚联合羟考酮与单纯对乙酰氨基酚治疗布洛芬治疗无效的急诊科肌肉骨骼疼痛患者的随机对照试验。

A randomized controlled trial of oxycodone/acetaminophen versus acetaminophen alone for emergency department patients with musculoskeletal pain refractory to ibuprofen.

机构信息

Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.

出版信息

Acad Emerg Med. 2021 Aug;28(8):859-865. doi: 10.1111/acem.14231. Epub 2021 Mar 12.

Abstract

BACKGROUND

Use of oral opioids does not result in more pain relief than nonopioid alternatives when administered to patients as first-line treatment for acute musculoskeletal pain. This study compared the efficacy of oxycodone/acetaminophen to that of acetaminophen alone as second-line treatment for patients with acute musculoskeletal pain who were administered prescription-strength ibuprofen and reported insufficient relief 1 h later.

METHODS

A randomized, double-blind study was conducted in two urban emergency departments. Opioid-naïve patients ≥ 18 years with an acute musculoskeletal injury were administered ibuprofen 600 mg as part of the study protocol. Those who reported insufficient relief 1 h later were randomized (1:1 ratio) to oxycodone 10 mg/acetaminophen 650 mg or acetaminophen 650 mg. The primary outcome was improvement in 0 to 10 pain scale between randomization and 2 h later. We also assessed medication-associated adverse events. A sample size calculation, built around a minimum clinically important difference of 1.3 units, determined the need for 154 patients.

RESULTS

We screened 924 patients and enrolled 393. All 393 received ibuprofen. A total of 159 (40%) patients reported inadequate relief after 1 h had elapsed. A total of 154 of these were randomized, 77 to oxycodone/acetaminophen and 77 to acetaminophen. Baseline characteristics were comparable. Among patients randomized to oxycodone/acetaminophen, mean (±SD) improvement in 0 to 10 pain scale was 4.0 (±2.6) versus 2.9 (±2.4) in the acetaminophen arm. The 95% confidence interval (CI) for the mean difference of 1.1 was 0.3 to 1.9. Among patients who received oxycodone/acetaminophen, 26 of 76 (34%) reported any medication-related adverse event versus seven of 74 (9%) participants who received acetaminophen. The 95% CI for the between-group difference of 25% was 12% to 37%).

CONCLUSION

Among patients with acute musculoskeletal pain refractory to oral ibuprofen, oxycodone/acetaminophen resulted in slightly greater pain relief than acetaminophen, but this was associated with more medication-related adverse events.

摘要

背景

对于急性肌肉骨骼疼痛患者,作为一线治疗药物,与非阿片类药物替代物相比,口服阿片类药物并没有带来更多的疼痛缓解。本研究比较了羟考酮/对乙酰氨基酚与单纯对乙酰氨基酚作为一线治疗药物的疗效,这些药物用于接受处方强度布洛芬治疗后 1 小时报告疼痛缓解不足的急性肌肉骨骼疼痛患者。

方法

在两个城市急诊部门进行了一项随机、双盲研究。纳入急性肌肉骨骼损伤且阿片类药物初治的年龄≥18 岁的患者,按照研究方案给予布洛芬 600mg。那些在 1 小时后报告疼痛缓解不足的患者随机(1:1 比例)接受羟考酮 10mg/对乙酰氨基酚 650mg 或对乙酰氨基酚 650mg。主要结局是随机分组至 2 小时时 0 到 10 疼痛评分的改善。我们还评估了与药物相关的不良事件。基于最小临床重要差异 1.3 个单位的样本量计算,确定需要纳入 154 例患者。

结果

我们共筛查了 924 例患者,纳入了 393 例。所有 393 例患者均接受了布洛芬治疗。1 小时后共有 159 例(40%)患者报告疼痛缓解不足。其中 154 例患者随机分组,77 例接受羟考酮/对乙酰氨基酚治疗,77 例接受对乙酰氨基酚治疗。基线特征相似。在接受羟考酮/对乙酰氨基酚治疗的患者中,0 到 10 疼痛评分的平均(±标准差)改善为 4.0(±2.6),而在接受对乙酰氨基酚治疗的患者中为 2.9(±2.4)。95%置信区间(CI)为 1.1 的均值差值为 0.3 至 1.9。在接受羟考酮/对乙酰氨基酚治疗的患者中,26 例(34%)报告了任何与药物相关的不良事件,而接受对乙酰氨基酚治疗的患者中 7 例(9%)报告了任何与药物相关的不良事件。组间差异的 95%CI 为 25%,即 12%至 37%。

结论

在对口服布洛芬疼痛缓解不足的急性肌肉骨骼疼痛患者中,羟考酮/对乙酰氨基酚比对乙酰氨基酚能稍微更有效地缓解疼痛,但这与更多的与药物相关的不良事件有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验